Nathan Joh

Amgen Inc.

Nate Joh is a Senior Scientist at Amgen attribute sciences department where he leads investigations to find the impact of molecular attributes on biological drug structure, function and safety. Prior to this, he developed thermodynamic protein drug stability methods at Bayer HealthCare. He received PhD at UCLA where he focused on structural biology, protein folding and structural informatics, and completed NIH postdoctoral training at Penn and UCSF where he performed computational protein design. He has published 10 first- or co-authored papers.


This speaker has made no appearances.